News
December 16, 2014

Legal Considerations For Pharmaceutical Brand Protection Programs

Bloomberg BNA's Pharmaceutical Law & Industry Report

By Ryan D. Guilds E. Alex Beroukhim
Find more content tagged:

People

Ryan D. Guilds
Ryan D. Guilds
Counsel
Washington, DC
+1 202.942.6188
Email
VCard
E. Alex Beroukhim
E. Alex Beroukhim
Partner
Los Angeles
+1 213.243.4059
Email
VCard

Related Content

October 28, 2020
FDA Seeks Comments on Medical Device Cybersecurity Communications Framework Discussion Paper
Advisory
October 23, 2020
China Proposed Measures To Implement Its Drug Patent Linkage System
Advisory
Subscribe
Subscribe Link

Email Disclaimer

Reject Accept